mRNA Treatment Market Size, Share and Trends Analysis 2025 to 2034

Report Id: 1110 Pages: 185 Last Updated: 30 May 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Global mRNA Treatment Market Size is estimated to be valued at 8.03 billion in 2024 and is predicted to reach 1.05 billion by the year 2031 at a 9.0% CAGR during 2028 to 2034.

mRNA Treatment Market Size, Share & Trends Analysis Report By Product Type (Prophylactic vaccines, Therapeutic vaccines, Therapeutic drugs), By Therapeutic Area, By Route of Administration, By Region, And Segment Forecasts, 2025 to 2034

Key Industry Insights & Findings from the Report:

  • The increasing existance of chronic diseases such as cancer, viral infections, and genetic disorders is driving the demand for mRNA treatments.
  • The development of advanced lipid nanoparticle formulations for in vivo systemic delivery of mRNA is fueling the mRNA treatment market.
  • North America dominated the market and accounted for a global revenue share in 2023.
  • The key challenges for the mRNA treatment market are process of vaccine and drug development is time-consuming and requires extensive clinical trials to ensure safety and efficacy. 

 The mRNA Treatment has various advantages, including vaccine preparation. mRNA is the biological preparation that induced active acquired immunity to a particular disease by stimulating the body’s immune system. Moreover, the advancement of lipid nanoparticle formulations for in vivo systemic delivery of mRNA fueling the development of in vivo transfection strategies.

The increasing prevalence of Cancer, viral infections, and genetic disorders drive the mRNA treatment market. Additionally, raising awareness about vaccination fueling the global mRNA market. Furthermore, mRNA is being used to produce viral antigen proteins from within the cell are one of the promising therapies for viral disease. For instance, due to the outbreak of COVID-19 number of companies conducting clinical trials for vaccine development is projected to create lucrative opportunities in the near future. North America is dominating the market owing to the presence of key players in the region.

Competitive Landscape

Some Of The Key Players In The mRNA Treatment Market:

  • CureVac,
  • Moderna,
  • BioNTech (Pfizer),
  • Translate Bio,
  • Ethris (AstraZeneca),
  • Kernal Biologics,
  • Anima Biotech,
  • H3 Biomedicine Inc.,
  • Arcturus Therapeutics,
  • eFFECTOR Therapeutics, Inc.,
  • Ionis Pharmaceuticals, Inc.,
  • Stemirna Therapeutics Co., Ltd.,
  • Skyhawk Therapeutics, Inc.,
  • RNAimmune (Sirnaomics),
  • Ziphius Therapeutics NV,
  • miRagen Therapeutics, Inc.,
  • Silence Therapeutics,
  • eTheRNA,
  • Tiba Biotechnology,
  • In-Cell-Art,
  • Arcturus Therapeutics

Market Segmentation

The Global mRNA Treatment market is segmented on the basis of product type, Therapeutic Area, Route of Administration, and region. Based on the product type, the market is divided into mRNA therapeutics and mRNA vaccines. On the basis of Therapeutic Area, the market is divided into Infectious Diseases, Oncological Disorders, Other Disorders. On the basis of Route of Administration, the market is divided into Intravenous, Intramuscular, Intranasal, and Others. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among that, Europe held the largest share of the market, followed by America and the Asia Pacific. On the other hand, North America is expected to dominate the market during the analysis of the forecast period.

Recent Developments:

  • In September 2023, Ethris and Heqet Therapeutics worked together to develop RNA-based cardiovascular therapeutics. Ethris granted the utilisation of its exclusive Stabilised NanoParticle (SNaP) lipid nanoparticle (LNP) platform in return for milestone and royalty payments as stipulated in this agreement. With an emphasis on remedies for heart failure and myocardial infarction, Heqet oversaw the drug development efforts.

mRNA Treatment Market Report Scope :

Report Attribute Specifications
Estimated Market Size Value In 2024 USD 8.03 Billion
Revenue Forecast In 2031 USD 1.05 Billion
Growth Rate CAGR CAGR of 9 % from 2028 to 2034
Quantitative Units Representation of revenue in US$ Million and CAGR from 2028 to 2034
Historic Year 2021 to 2024
Forecast Year 2028-2034
Report Coverage The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered By Product Type, By Therapeutic Area, By Route of Administration
Regional Scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia
Competitive Landscape CureVac, Moderna, BioNTech (Pfizer), Translate Bio, Ethris (AstraZeneca), Kernal Biologics, Anima Biotech, H3 Biomedicine Inc., Arcturus Therapeutics, eFFECTOR Therapeutics, Inc., Ionis Pharmaceuticals, Inc., Stemirna Therapeutics Co., Ltd., Skyhawk Therapeutics, Inc., RNAimmune (Sirnaomics), Ziphius Therapeutics NV, miRagen Therapeutics, Inc., Silence Therapeutics, eTheRNA, Tiba Biotechnology, In-Cell-Art, Arcturus Therapeutics among others.
Customization Scope Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.
Pricing And Available Payment Methods Explore pricing alternatives that are customized to your particular study requirements.

mRNA Treatment Market Segmentation:

mRNA Treatment Market Revenue (US$ Mn) by Product Type

  • mRNA Therapeutic
  • mRNA Vaccines

mRNA Treatment Market Revenue (US$ Mn) Based on Therapeutic Area

  • Infectious Diseases
  • Oncological Disorders
  • Other Disorders

mRNA Treatment Market Revenue (US$ Mn) Based on Route of Administration

  • Intravenous
  • Intramuscular
  • Intranasal
  • Others 

mRNA Treatment Market Revenue (US$ Mn) Based on Region

Europe mRNA Treatment Market Revenue (US$ Mn) by Country

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

North America mRNA Treatment Market Revenue (US$ Mn) by Country

  • U.S.
  • Canada

Asia Pacific mRNA Treatment Market Revenue (US$ Mn) by Country

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America mRNA Treatment Market Revenue (US$ Mn) by Country

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa mRNA Treatment Market Revenue (US$ Mn) by Country

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
3078
Security Code field cannot be blank!

Frequently Asked Questions

The Global mRNA Treatment Market Size is estimated to be valued at 8.03 billion in 2024 and is predicted to reach 1.05 billion by the year 2031 at a 9

The Global mRNA Treatment Market is expected to grow at a 9% CAGR during 2028-2034.

CureVac, Moderna, BioNTech (Pfizer), Translate Bio, Ethris (AstraZeneca), Kernal Biologics, Anima Biotech, H3 Biomedicine Inc., Arcturus Therapeutics,
Get Sample Report Enquiry Before Buying